1.
Pediatr Allergy Immunol
; 19(6): 564-8, 2008 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18844858
RESUMO
We are reporting on a 7-months-old boy with suspected hyper-IgE syndrome, presenting with a therapy resistant severe eczema and an overall reduction of in vitro cytokine production. Interferon-alpha (IFN-alpha) treatment resulted in a marked and stable clinical improvement and normalization of in vitro T-cell cytokine production, indicating a valid therapeutic potential of IFN-alpha as immunomodulating drug.